![](https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2022/07/01/netfliximage.png)
- Piper Sandler cut The Goldman Sachs Group, Inc. (NYSE:GS) price target from $430 to $410. Goldman Sachs shares fell 0.1% to $296.79 in pre-market trading.
- Benchmark lowered Western Digital Corporation (NASDAQ:WDC) price target from $85 to $65. Western Digital shares fell 3.4% to $43.31 in pre-market trading.
- Raymond James cut the price target on Micron Technology, Inc. (NASDAQ:MU) from $115 to $72. Micron shares slipped 4.9% to $52.60 in pre-market trading.
- Credit Suisse cut the price target on Walgreens Boots Alliance, Inc. (NASDAQ:WBA) from $52 to $43. Walgreens shares dropped 0.1% to $37.85 in pre-market trading.
- Truist Securities reduced Netflix, Inc. (NASDAQ:NFLX) price target from $300 to $210. Netflix shares fell 0.8% to $173.54 in pre-market trading.
Check out this: Akebia Therapeutics And 20 Stocks Moving Premarket
- HC Wainwright & Co. cut Renalytix Plc (NASDAQ:RNLX) price target from $30 to $15. Renalytix shares fell 38.3% to close at $2.45 on Thursday.
- Keybanc cut SBA Communications Corporation (NASDAQ:SBAC) price target from $393 to $367. SBA Communications shares fell 2.2% to $313.00 in pre-market trading.
- SVB Leerink reduced the price target for Talaris Therapeutics, Inc. (NASDAQ:TALS) from $21 to $7. Talaris Therapeutics shares fell 36.8% to close at $4.51 on Thursday.
- Stifel lowered price target for Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) from $176 to $142. Ultragenyx Pharmaceutical shares fell 1% to close at $59.66 on Thursday.
- Barclays reduced the price target on Verisk Analytics, Inc. (NASDAQ:VRSK) from $220 to $200. Verisk Analytics shares rose 1% to close at $173.09 on Thursday.
Don’t forget to check out our premarket coverage here .